Metropolitan Life Insurance Company (MetLife)’s Equifax EFX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-4,973
| Closed | -$1.33M | – | 650 |
|
|
2024
Q1 | $1.33M | Sell |
4,973
-43
| -0.9% | -$10.9K | 0.06% | 279 |
|
|
2023
Q4 | $1.24M | Sell |
5,016
-61
| -1% | -$12.4K | 0.06% | 280 |
|
|
2023
Q3 | $930K | Sell |
5,077
-268
| -5% | -$54.7K | 0.05% | 307 |
|
|
2023
Q2 | $1.26M | Sell |
5,345
-134
| -2% | -$28.2K | 0.06% | 278 |
|
|
2023
Q1 | $1.11M | Sell |
5,479
-1,463
| -21% | -$305K | 0.06% | 302 |
|
|
2022
Q4 | $1.35M | Sell |
6,942
-86
| -1% | -$15.7K | 0.06% | 300 |
|
|
2022
Q3 | $1.2M | Sell |
7,028
-84
| -1% | -$16.5K | 0.06% | 311 |
|
|
2022
Q2 | $1.3M | Sell |
7,112
-161
| -2% | -$32.2K | 0.06% | 309 |
|
|
2022
Q1 | $1.72M | Sell |
7,273
-8,558
| -54% | -$2.02M | 0.06% | 293 |
|
|
2021
Q4 | $4.64M | Sell |
15,831
-537
| -3% | -$149K | 0.06% | 244 |
|
|
2021
Q3 | $4.15M | Sell |
16,368
-536
| -3% | -$139K | 0.06% | 253 |
|
|
2021
Q2 | $4.05M | Sell |
16,904
-2,679
| -14% | -$599K | 0.06% | 272 |
|
|
2021
Q1 | $3.55M | Sell |
19,583
-1,087
| -5% | -$192K | 0.05% | 303 |
|
|
2020
Q4 | $3.99M | Sell |
20,670
-827
| -4% | -$139K | 0.06% | 254 |
|
|
2020
Q3 | $3.37M | Sell |
21,497
-878
| -4% | -$144K | 0.06% | 271 |
|
|
2020
Q2 | $3.85M | Sell |
22,375
-394
| -2% | -$58.4K | 0.07% | 225 |
|
|
2020
Q1 | $2.72M | Sell |
22,769
-295
| -1% | -$42.9K | 0.06% | 286 |
|
|
2019
Q4 | $3.23M | Sell |
23,064
-74
| -0.3% | -$10.3K | 0.05% | 323 |
|
|
2019
Q3 | $3.25M | Buy |
23,138
+3,527
| +18% | +$497K | 0.06% | 302 |
|
|
2019
Q2 | $2.65M | Buy |
19,611
+1,275
| +7% | +$160K | 0.04% | 375 |
|
|
2019
Q1 | $2.17M | Sell |
18,336
-649
| -3% | -$69.3K | 0.04% | 451 |
|
|
2018
Q4 | $1.77M | Sell |
18,985
-63
| -0.3% | -$6.71K | 0.04% | 497 |
|
|
2018
Q3 | $2.49M | Sell |
19,048
-610
| -3% | -$79.5K | 0.04% | 404 |
|
|
2018
Q2 | $2.46M | Sell |
19,658
-4,284
| -18% | -$508K | 0.04% | 410 |
|
|
2018
Q1 | $2.82M | Buy |
23,942
+109
| +0.5% | +$13.1K | 0.04% | 351 |
|
|
2017
Q4 | $2.81M | Sell |
23,833
-38,324
| -62% | -$4.31M | 0.04% | 353 |
|
|
2017
Q3 | $6.59M | Sell |
62,157
-727
| -1% | -$96.1K | 0.04% | 417 |
|
|
2017
Q2 | $8.64M | Sell |
62,884
-874
| -1% | -$120K | 0.06% | 303 |
|
|
2017
Q1 | $8.72M | Sell |
63,758
-812
| -1% | -$103K | 0.06% | 305 |
|
|
2016
Q4 | $7.63M | Sell |
64,570
-1,600
| -2% | -$196K | 0.05% | 338 |
|
|
2016
Q3 | $8.9M | Sell |
66,170
-665
| -1% | -$88.2K | 0.07% | 278 |
|
|
2016
Q2 | $8.58M | Sell |
66,835
-514
| -0.8% | -$62.3K | 0.06% | 286 |
|
|
2016
Q1 | $7.7M | Sell |
67,349
-792
| -1% | -$83.3K | 0.06% | 305 |
|
|
2015
Q4 | $7.59M | Sell |
68,141
-1,047
| -2% | -$113K | 0.06% | 310 |
|
|
2015
Q3 | $6.72M | Sell |
69,188
-1,575
| -2% | -$156K | 0.05% | 359 |
|
|
2015
Q2 | $6.87M | Buy |
70,763
+2,130
| +3% | +$208K | 0.05% | 393 |
|
|
2015
Q1 | $6.38M | Sell |
68,633
-1,457
| -2% | -$129K | 0.05% | 411 |
|
|
2014
Q4 | $5.67M | Sell |
70,090
-464
| -0.7% | -$35.9K | 0.04% | 476 |
|
|
2014
Q3 | $5.27M | Sell |
70,554
-1,236
| -2% | -$94.1K | 0.04% | 474 |
|
|
2014
Q2 | $5.21M | Sell |
71,790
-5,577
| -7% | -$391K | 0.04% | 518 |
|
|
2014
Q1 | $5.26M | Sell |
77,367
-990
| -1% | -$69.2K | 0.04% | 507 |
|
|
2013
Q4 | $5.41M | Sell |
78,357
-1,282
| -2% | -$83.4K | 0.04% | 482 |
|
|
2013
Q3 | $4.77M | Sell |
79,639
-236
| -0.3% | -$14.5K | 0.04% | 502 |
|
|
2013
Q2 | $4.71M | Buy |
+79,875
| New | +$4.82M | 0.04% | 471 |
|
Other funds holding EFX
GIM
Metropolitan Life Insurance Company (MetLife)'s EFX Position: Q2 2024 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Equifax (EFX) in Q2 2024, closing a stake of 4,973 shares — an estimated $1.33M sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in EFX in Q2 2013 and held it in 44 quarters. The position peaked at $8.9M in Q3 2016. 758 funds tracked by Wall St. Rank hold EFX as of Q2 2024.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Equifax position as of Q2 2024 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 4,973 Equifax shares in Q2 2024, an estimated $1.33M.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Equifax in Q2 2013 and held it in 44 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Equifax position peaked at $8.9M in Q3 2016.
- 758 funds tracked by Wall St. Rank held Equifax as of Q2 2024.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.